Taevas
ColombiaPharmaceuticals
Legal Representation
Legal Representation for Pharmaceuticals in Colombia
Entering the Colombian pharmaceuticals market requires a qualified local Legal Representative registered with INVIMA before any product authorization can be granted. Taevas Global provides the in-country legal representation infrastructure that foreign ma
Market
Colombia
Industry
Pharmaceuticals
Service
Legal Representation
Regulator
INVIMA
Timeline
4-8 weeks
What We Deliver
Six Pillars of Colombia Pharmaceuticals Intelligence
Our legal representation service is built on six interconnected pillars that cover every dimension of regulatory compliance, market access, and ongoing operational support for pharmaceuticals companies in Colombia.
01
INVIMA Registration Management
We act as your officially registered Legal Representative before INVIMA, the Instituto Nacional de Vigilancia de Medicamentos y Alimentos, which is mandatory for any foreign manufacturer seeking a Registro Sanitario in Colombia. Our team prepares, submits, and tracks all dossiers in accordance with Decree 677 of 1995 and subsequent resolutions. We manage the full lifecycle from initial submission through renewal and post-approval variations.
Qualified Person designation accepted by INVIMA
Dossier preparation under CTD and local format requirements
Renewal and variation management throughout product lifecycle
How It Works
From Brief to Board-Ready Intelligence
Our four-step engagement model moves you from initial scoping to fully activated legal representation in Colombia with clear milestones, transparent timelines, and dedicated regulatory counsel at every stage.
Step 1 · Day 1-3
Intake and Portfolio Assessment
We begin with a structured intake session to map your product portfolio, target therapeutic categories, manufacturing site locations, and existing approvals in reference markets such as the FDA, EMA, or INVIMA-recognized countries. This assessment determines the optimal registration pathway for each product and surfaces any documentation gaps that must be resolved before filing. You receive a written scope confirmation and fee proposal within 72 hours.
Taevas Approach
The intake process uses a standardized questionnaire covering active pharmaceutical ingredients, dosage forms, manufacturing sites, GMP certification status, existing CTD dossiers, and desired Colombian launch timeline. Our regulatory affairs team cross-references your portfolio against the current INVIMA register to identify potential conflicts, existing similar products, and pricing reference points under the SISMED system.
Market Snapshot
Colombia Pharmaceuticals Market at a Glance
$0B+
Annual Pharmaceutical Market Value (USD)
0%
Projected Annual Market Growth Rate
0+
Active Foreign Manufacturers Registered
0+
Active Registros Sanitarios in Force
INVIMA as Regional Gateway
Colombia's INVIMA is recognized as one of the most rigorous regulatory agencies in Latin America, and an INVIMA Registro Sanitario is increasingly used as a reference for market entry into neighboring Andean Community countries including Peru, Ecuador, and Bolivia. Companies that establish strong compliance records with INVIMA gain a credibility advantage across the broader Andean region. This makes Colombia a strategically valuable first market for companies building a Latin American pharmaceuticals portfolio.
Mandatory Local Representative Requirement
Colombian law under Decree 677 of 1995 and subsequent INVIMA resolutions requires every foreign pharmaceutical manufacturer to designate a legally registered local representative before any Registro Sanitario application can be accepted. This representative bears joint legal responsibility for product quality, safety reporting, and regulatory correspondence. Operating without a compliant local representative exposes manufacturers to product seizure, import suspension, and administrative sanctions.
Growing Generic and Biosimilar Segment
Colombia's government has actively promoted generic and biosimilar adoption through public procurement policies and mandatory international nonproprietary name prescribing in the public health system. The biosimilar regulatory framework established under Resolution 3610 of 2013 and updated guidelines creates a structured pathway for biological products, though requirements remain more demanding than for small molecule generics. This segment represents a significant growth opportunity for manufacturers with established bioequivalence data packages.
Digital Regulatory Infrastructure Expansion
INVIMA has invested substantially in its VITAL digital platform for online dossier submission and tracking, reducing paper-based processing delays and improving transparency for applicants. The agency has also introduced electronic certificates of pharmaceutical product and expanded its capacity for virtual inspections of foreign manufacturing sites. Manufacturers who engage legal representatives with fluency in INVIMA's digital systems gain meaningful processing time advantages over those relying on legacy paper workflows.
What's Included
Everything in Your Engagement
Every Taevas Global legal representation mandate for Colombia pharmaceuticals includes these eight core deliverables, ensuring complete regulatory coverage from initial filing through ongoing post-market compliance.
Portfolio Regulatory Gap Analysis
A written assessment of each product in your portfolio identifying the correct INVIMA registration pathway, documentation gaps, and estimated timeline and cost to authorization.
INVIMA Dossier Preparation
Full compilation of the Registro Sanitario application dossier in Spanish, adapted to Colombian format requirements and submitted electronically through the INVIMA VITAL platform.
Deficiency Letter Response Management
Scientifically substantiated written responses to all INVIMA technical queries, prepared within regulatory deadlines and coordinated with your global regulatory affairs team.
Legal Representative Agreement
A formal bilateral agreement defining the scope of representation, liability allocation, termination conditions, and regulatory obligations of both parties under Colombian law.
Import Permit and DIAN Coordination
Management of import authorization filings with INVIMA and coordination with DIAN customs for pharmaceutical product importation, including controlled substance permits where applicable.
Pharmacovigilance Unit Setup
Establishment and operation of your mandatory pharmacovigilance program in Colombia, including adverse event reporting to INVIMA and Periodic Safety Update Report preparation.
Compliance Calendar and Monitoring
A rolling compliance calendar covering renewal deadlines, variation filing windows, pharmacovigilance reporting dates, and real-time monitoring of INVIMA regulatory updates affecting your products.
Dedicated Account Management
A named Taevas regulatory account manager providing quarterly compliance status reports, ad hoc regulatory query support, and representation coordination for INVIMA inspections or hearings.
Who This Is For
Built for These Situations
Market Entry
Foreign Manufacturer Entering Colombia for the First Time
Your company has approved products in the US, EU, or other reference markets and wants to access Colombia's growing pharmaceuticals sector without establishing a local subsidiary. You need a credible, legally compliant local representative who can file and manage Registro Sanitario applications on your behalf and bear the regulatory responsibilities required by INVIMA. Speed to market and regulatory reliability are your primary concerns.
Outcome
Fully registered Legal Representative relationship with INVIMA within 30 days, first Registro Sanitario dossier submitted within 8 weeks.
Next Steps
After Legal Representation, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Map Your Colombia Opportunity?
Whether you are entering Colombia for the first time, transitioning from an underperforming representative, or expanding an existing portfolio, Taevas Global provides the regulatory infrastructure and legal representation expertise to move you from intent to authorized market presence. Speak with our Colombia pharmaceuticals team today.
INVIMA-registered Legal Representative active within 30 days
Full dossier preparation and submission management included
Pharmacovigilance unit setup and operation covered
Dedicated account manager with Colombia regulatory expertise